期刊文献+

肿瘤患者药品不良反应的相关因素分析 被引量:2

Related factors analysis on adverse drug reaction of patients with tumor
暂未订购
导出
摘要 目的分析肿瘤患者药品不良反应(ADRs)的相关因素。方法对我院2006年12月~2011年6月收集的266例肿瘤患者进行回顾性分析。结果 ADRs中男性明显多于女性;从年龄结构上来看,发生ADRs的年龄段主要集中于40~69岁;损害部位主要以皮肤及其附件、神经系统、血液系统、胃肠系统、肝胆系统、心血管系统、用药部位及全身性损害为主。结论在肿瘤药品的临床应用上,应该加强对不良反应的监测和预防。 Objective To analyze the related factor on adverse drug reaction of patients with tumor.Methods 266 patients with tumor in our hospital from December 2006 to June 2011 were collected and analyzed retrospectively.Results The number of men in the ADRs was obviously more than the number of women;from the perspective of age structure,the mainly age of ADRs focused on 40 to 69 years old;ADRs mainly damaged to the skin and its attachments,nervous system,blood system,gastrointestinal system,treating system,cardiovascular system,the administration site and systemic damage.Conclusion Clinical application of cancer drugs should strengthen the monitoring and prevention of adverse reactions.
出处 《中国医药导报》 CAS 2012年第30期118-120,共3页 China Medical Herald
关键词 抗肿瘤药品 药品不良反应 分析 Antitumor drugs Adverse drug reaction Analysis
  • 相关文献

参考文献10

二级参考文献26

  • 1孙燕,石元凯.临床肿瘤内科手册[M].第5版.北京:人民卫生出版社,2009:606-607.
  • 2Ajanj JA.Docetaxel for gastric and esophageal carcin om as[J].Oncology,2002,16(6):89-96.
  • 3SULKED,A,SMYTH J,SESSA C,et a1.Docetaxel(Taxotere) in advanced gastric cancer;results of a phase Ⅱ clinical trial.EORTC Early Clinical Trials Group[J].Br J Cancer,1994,70:380—383.
  • 4TAGUCHI T,SAKATA Y,KANAMARU R,et a1.Late phase Ⅱ clinical study of RP56976(docetaxel)in patients with advanced/recurrent gastric Cancer:a Japanese Cooperative Study Group trial (group A)[J].Gan To Kagaku Ryoho,1998,25:1915—1924.
  • 5BANG Y J,KANG W K,KANG Y K.Docetaxel 75 ms/m^2 is active and well tolerated in patients with metastatic or recurrent gastric cancer:a phase Ⅱ trial[J].Jpn J Clin Oncol,2002,32:248—254.
  • 6AJANI J A.Docetaxel for gastric and esophageal carcinomas[J]. Ontology(Huntingt),2002,6:89-96.
  • 7MITACHIY,SAKATAY,OHTSUA,et a1.Docetaxel and cispla.tin in patients with advanced or recurrent gastric canceri a multicenter phase I/Ⅱ study[J].Gastric Cancer,2002,5:160-167.
  • 8HAlJ.ER D G,MISSET J L.Docetaxel in advanced gastric cancer[J].Anticancer Drugs,2002,13:451-460.
  • 9ROTH A D,MAIBACH R,MARTINELLI G,et a1.DoceLaxel (Taxotere)-cisplatin(TC):an effective drug combination in gastric carcinoma.Swiss Group for Clinical Cancer Research(SAKK),and the European Institute of Oncology(EIO)[J].Ann Oncol,2000,11:301—306.
  • 10RIDWELSKI K, GEBAUER T, FAHLKE J, et al. Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer[J]. Ann Oncol,2001,12:47-51.

共引文献94

同被引文献31

引证文献2

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部